Gufic Biosciences Limited (GUFICBIO) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Gufic Biosciences Limited stock ₹73.40, price ₹473, that is 84.5% below the price, quality 44 out of 100. Rating: strongly overvalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Gufic Biosciences Limited
GUFICBIO · NSEFar too expensive (fair value 85% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range ₹171.46 – ₹487.00 · fair‑value band ₹49.34 – ₹125.21 · the ₹473.05 price screens above the ₹73.40 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Gufic Biosciences is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America.
Show moreShow less
The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals.
It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments.
In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. Further, it engages in contract and bulk drug manufacturing business.
Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.
Stock analysis
Gufic Biosciences Limited (GUFICBIO) currently trades at ₹473.05, while our model-based Fair Value estimate is ₹73.40, 85% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹162.19 per share, and 0 of the 17 models we run sit above the ₹473.05 price.
Bear case: the Asset-Based group reads lowest at ₹12.43, and 17 of the 17 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹49.34 (bear) to ₹125.21 (bull), the price of ₹473.05 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Gufic Biosciences Limited reported revenue of ₹9.4B in FY2026 versus ₹7.8B in FY2022, a compound +4.9%/yr. Reported net income was ₹642M in FY2026, compounding −9.5%/yr from FY2022.
Key figures
Market cap ₹47.5B (≈ $504M) Small · P/E ratio 64.6 · P/S ratio 4.84 · EPS (TTM) ₹7.32 · Dividend yield 0.0% · Net margin 7.5% · Return on equity 10.1% · Return on assets (EBIT) 19.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (medium confidence).
What moves the price
The share trades about 3% below its 52-week high and 73% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −85%, GUFICBIO screens richer than that median.
Fair Value models
All 17 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
GUFICBIO screens overvalued: fair value 85% below the price. Compare with Merck KGaA →
Compare Gufic Biosciences Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 605 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs GUFICBIO |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.07 | ¥53.04 | +10% | vs GUFICBIO |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,880 | ₹1,983 | +5% | vs GUFICBIO |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs GUFICBIO |
| Merck KGaA MRK | €149.60 | €108.83 | −27% | vs GUFICBIO |
| Galderma Group GALD | CHF 191.40 | CHF 112.30 | −41% | vs GUFICBIO |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs GUFICBIO |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs GUFICBIO |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs GUFICBIO |
| Divi's Laboratories Limited DIVISLAB | ₹11,442 | ₹1,567 | −86% | vs GUFICBIO |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Gufic Biosciences Limited (GUFICBIO) overvalued or undervalued?
What is the fair value of GUFICBIO?
What is the quality score of GUFICBIO?
What is the price target for Gufic Biosciences Limited (GUFICBIO)?
What is the Gufic Biosciences Limited stock forecast for 2026?
What is the revenue of Gufic Biosciences Limited (GUFICBIO)?
Does Gufic Biosciences Limited pay a dividend?
How much is the dividend of Gufic Biosciences Limited (GUFICBIO) and when is the ex-dividend date?
What is the intrinsic value of Gufic Biosciences Limited (GUFICBIO)?
Is Gufic Biosciences Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of GUFICBIO?
How much is Gufic Biosciences Limited worth?
What do the bullish and bearish scenarios say about GUFICBIO?
What is the P/E ratio of GUFICBIO?
How solid is the balance sheet of Gufic Biosciences Limited (GUFICBIO)?
How far is GUFICBIO from its 52-week high?
Which stocks are comparable to Gufic Biosciences Limited?
Is Gufic Biosciences Limited stock attractive at the current price?
How is the fair value of GUFICBIO calculated?
Is it still worth investing in stocks now?
What is the share price of Gufic Biosciences Limited (GUFICBIO)?
What should I pay attention to with Gufic Biosciences Limited right now?
Where does the earnings growth of Gufic Biosciences Limited (GUFICBIO) come from?
Key figures of Gufic Biosciences Limited
How large is the market capitalisation of Gufic Biosciences Limited (GUFICBIO)?
What is the P/S ratio of Gufic Biosciences Limited (GUFICBIO)?
What are the earnings per share of Gufic Biosciences Limited (GUFICBIO)?
What is the dividend yield of Gufic Biosciences Limited (GUFICBIO)?
What is the net margin of Gufic Biosciences Limited (GUFICBIO)?
What is the return on equity of Gufic Biosciences Limited (GUFICBIO)?
What is the EBIT return on assets of Gufic Biosciences Limited (GUFICBIO)?
What is the operating margin of Gufic Biosciences Limited (GUFICBIO)?
How fast is revenue growing at Gufic Biosciences Limited (GUFICBIO)?
How fast are earnings growing at Gufic Biosciences Limited (GUFICBIO)?
How much free cash flow does Gufic Biosciences Limited (GUFICBIO) generate?
How much net debt does Gufic Biosciences Limited (GUFICBIO) carry?
Watch Gufic Biosciences Limited in the live analysis
One click puts Gufic Biosciences Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.